Iceland: Sidekick Health Secures €35 Million Venture Debt from EIB to Accelerate R&D and Global Expansion
The European Investment Bank (EIB) and Sidekick Health — a global leader in integrated digital health and therapeutics — today announced the signing of a €35 million venture debt facility, backed by a dedicated life science venture debt window of... Read More →
Vonova’s Successful Seed Financing for Revolutionary Brain Access Technology
Vonova’s Successful Seed Financing for Revolutionary Brain Access Technology NIH-supported neurotechnology startup secures investment from XEIA, Device of Tomorrow Capital, and SmartGate VC BETHESDA, MD – April 28, 2025 – Vonova Inc. has secured seed financing from a consortium of... Read More →
Sonavex Receives FDA 510(k) Clearance for EchoMap™ Device
Baltimore, MD (April 28th, 2025) – Sonavex, Inc., a privately held medical device company with ultrasound technologies that deliver quantitative blood flow and other critical vascular data at the point of care, announced today that it has received U.S. Food... Read More →
Zenflow announces Spring System data for benign prostatic hyperplasia
The studies, which included 72 participants, utilised IPSS and IPSS-QOL to measure symptom improvement. Medical device company Zenflow has reported that its Spring System demonstrated durable benefits three years post-placement for individuals with benign prostatic hyperplasia (BPH) in the ZEST... Read More →
Early cancer detection startup Craif raises $22M
Cancer ranks as one of the top causes of death worldwide. The National Cancer Institute reported nearly 20 million new cancer cases and 9.7 million cancer-related deaths globally in 2022, with projections showing a rise to 29.9 million new cases... Read More →
KA Imaging obtains CE Mark for mobile x-ray system
Canadian x-ray manufacturer KA Imaging has received the CE Mark for its Reveal Mobi Lite mobile x-ray system, which is now available for sale across the European Union. The Reveal Mobi Lite mobile imaging system, integrating SpectralDR technology and the... Read More →
Biolinq Announces Close of $100M Series C Financing to Advance Its Biowearable Platform for Metabolic Health
SAN DIEGO–(BUSINESS WIRE)–Biolinq Incorporated, a healthcare technology company pioneering precision multi-analyte biosensors to improve metabolic health, today announced a $100 million Series C financing led by Alpha Wave Ventures, with participation from existing investors RiverVest Venture Partners, AXA IM Alts,... Read More →
Prapela, Inc. Granted FDA De Novo for Breakthrough Therapy Helping the Most Vulnerable Victims of our Opioid Epidemic
Prapela’s SVS hospital bassinet pad is the first and only therapeutic medical device to treat opioid exposed newborns with neonatal opioid withdrawal syndrome. PORTLAND, ME, UNITED STATES, April 17, 2025 /EINPresswire.com/ — One of the more sorrowful consequences of our... Read More →
Approval Through FDA’s De Novo Pathway: A Major Accomplishment! featuring Osteoboost
In January 2024, Osteoboost achieved a notable regulatory milestone by receiving De Novo classification from the U.S. Food and Drug Administration (FDA). This designation is significant not only because FDA approval is a rigorous process but also because Osteoboost was... Read More →
Impact Ventures by J&J Foundation invests in Mobio Interactive, unlocking the benefit of “precision psychiatry at scale” for patients and healthcare workers around the world
One of the major challenges that has plagued mental health healthcare, is that of subjectivity. This was the impetus for the development of Mobio Interactive’s innovative technology designed to deliver “precision psychiatry at scale” for patients around the world. “The... Read More →